Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P29
Within normal range
vs 2Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-39.55%
202472.94%
202382.21%
2022-11.01%
20218.49%
2020-105.14%
201913.23%
2018-15.26%
2017-29.77%
2016-60.64%